Thirty-seven state attorneys general have urged Congress to ban hemp-derived THC products, citing health and enforcement concerns. Their unified call for federal action could reshape the future of hemp regulation — and impact every operator in the space.

Pennsylvania lawmakers advanced a bill to create a Cannabis Control Board that would oversee both medical marijuana and hemp-derived products. The move emphasizes regulatory reform and consumer safety, not adult-use legalization — but it could set the stage for a more unified and professional cannabis framework.

Cannabis stocks like Tilray, Canopy Growth, and Greenlane are seeing renewed investor attention thanks to increased trading volume and optimism around policy reform. Here’s what’s driving the resurgence — and what it means for the future of cannabis business and investment.